SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-23-053836
Filing Date
2023-02-28
Accepted
2023-02-28 16:11:13
Documents
13
Period of Report
2023-02-28
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d448965d8k.htm   iXBRL 8-K 39130
  Complete submission text file 0001193125-23-053836.txt   211047

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA ebac-20230228.xsd EX-101.SCH 4605
3 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE ebac-20230228_def.xml EX-101.DEF 14411
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE ebac-20230228_lab.xml EX-101.LAB 24344
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ebac-20230228_pre.xml EX-101.PRE 15444
7 EXTRACTED XBRL INSTANCE DOCUMENT d448965d8k_htm.xml XML 7267
Mailing Address EPFL INNOVATION PARK BUILDING LAUSANNE V8 1015
Business Address EPFL INNOVATION PARK BUILDING LAUSANNE V8 1015 41 77 976 21 09
European Biotech Acquisition Corp. (Filer) CIK: 0001841258 (see all company filings)

IRS No.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40211 | Film No.: 23685345
SIC: 6770 Blank Checks